T raumatic brain injury (TBI) causes approximately 2200 deaths and 35 000 hospitalizations among US children annually. 1 Children who survive severe TBI frequently have new motor, communication, and/or behavioral morbidities. 2, 3 Elevated intracranial pressure (ICP) often results from severe TBI and worsens patient outcome by causing additional brain injury. 4, 5 Intracranial pressure monitoring is used to detect elevated ICP and to guide treatment of severe TBI. The overall association of ICP monitoring with patient outcome is unclear. Therapies to reduce ICP are mainstays of treatment for severe TBI, and the treatment of elevated ICP is associated with the best reported outcomes. 4, [6] [7] [8] However, because of the relatively low quality of evidence, the current guidelines for the medical care of children with severe TBI state only that ICP monitoring "may be considered" for children with severe TBI. 4(pS11) Perhaps because of the weak evidence but despite the current guidelines, studies have shown that hospitals use ICP monitoring for children with severe TBI at variable rates. [9] [10] [11] [12] Studies of ICP monitoring are complicated by this existing expert recommendation, and sufficient equipoise for a randomized clinical trial is unlikely. Without the necessary equipoise to conduct a clinical trial, several multicenter observational studies addressing this question have been published. Some of those studies support ICP monitoring, 8, 9 whereas others report mixed results or no association of ICP monitoring with patient outcome. 12, 13 All have been limited by 1 or more issues: small sample size, inadequate severity and confounder adjustment due to missing variables, database codes with unknown accuracy, mortality as the only outcome, or lack of consideration of clustering of patient outcomes by hospital. 8 To overcome the limitations of small sample size and missing variables, we probabilistically linked 2 large, overlapping databases that each contain a portion of the necessary information: the Pediatric Health Information System (PHIS) database and the National Trauma Data Bank (NTDB). 14 The PHIS database contains rich clinical information, particularly regarding treatments such as medications and nursing interventions. The NTDB is a standardized collection of hospital trauma registries that contains the necessary injury variables but does not contain detailed treatment data. To address the uncertain accuracy of database codes, we developed and prospectively validated computable phenotypes (sets of data elements and logical expressions that identify a clinical condition or characteristic) 15 to identify ICP monitoring, other key neurosurgical and critical care interventions, and a proxy functional outcome. 16, 17 We then conducted this propensityweighted comparative effectiveness analysis testing the hypothesis that ICP monitoring is associated with improved functional survival of children with severe TBI.
Methods

Data Sources and Cohort Design
The PHIS-NTDB linkage that generated this data set has been described in detail. 14, 18 Additional information is available in the eAppendix in the Supplement. This study was approved by the University of Utah Institutional Review Board and the Colorado Multiple Institutional Review Board, and written permission was obtained from both the Children's Hospital Association (PHIS owner) and the American College of Surgeons (NTDB owner). Patient and parental consent was waived by both institutional review boards.
Inclusion and Exclusion Criteria
We defined TBI using the 19, 20 ) in the primary analysis, we defined an exposure period (24 hours after admission) and an observation period (after the first 24 hours of admission). Children who died or were discharged before 24 hours had elapsed were excluded from the study population, 19 and children who underwent ICP monitors after 24 hours were placed in the untreated group ( Figure 1 ) for all analyses.
Key Points
Question Does intracranial pressure monitoring improve the functional survival of children with severe traumatic brain injury?
Findings In a propensity-weighted effectiveness analysis using 2 linked national databases, no statistically significant difference was found in functional survival between children who underwent intracranial pressure monitoring and those who did not.
Meaning Because intracranial pressure monitoring is a widely but inconsistently used technology with incompletely demonstrated effectiveness, a large prospective cohort study or randomized trial is needed.
The primary outcome was a composite of mortality, discharge to hospice, 21 22 The SMD, which compares differences in mean values using the unit of the pooled SD, is the criterion standard for assessment of covariate balance in propensity analyses. 23 This approach is less sensitive to sample size than typical inferential testing. Standardized mean differences greater than 10% are generally considered meaningful.
Propensity Model
Propensity methods are based on the estimation of a single variable that defines the likelihood of having received the treatment in question as a function of the background differences.
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They are particularly useful when the outcome occurs less often than the treatment, as is the case in this study. The goal of the propensity model is covariate balance between the treated (those who underwent ICP monitoring) and untreated groups. Good covariate balance is considered to be present if all SMDs in a propensity model are less than 10%. 23 We used a machine learning approach, generalized boosted regression, to achieve optimal covariate balance. 25 To do so, we calculated each patient's probability (propensity) of ICP monitoring as implemented by the twang package in R. 26 We targeted the smallest maximum SMD as the stopping rule for the generalized boosted regression process. No variable had an SMD greater than 5% in the final propensity model (using matching weights; eFigure 1 in the Supplement).
Covariates in the propensity model include demographic characteristic, clinical events, types of injury, neurologic examinations, and hospital capability variables (eTable 2 in the Supplement). After we built the propensity model, we examined the distribution of propensity scores stratified by actual receipt of ICP monitoring ( Figure 2) . Three of 50 children with a propensity score greater than 0.85 did not undergo ICP monitoring. To restrict the outcome analysis to the area of common support 27 (where a child might receive or not receive an ICP monitor), we excluded the 50 children with propensity scores greater than 0.85.
Primary Outcome Model
To preserve the statistical power of the outcome analysis and avoid multiple testing, we finalized the propensity model and prespecified the design of the outcome model before any outcome assessment. After estimating the propensity score, we applied weighted logistic regression with clustering by hospital 28 to estimate the association of ICP monitoring with mortality (which included discharge to hospice) or poor functional survival (yes or no). No covariates were included in the primary outcome model. The analysis achieved covariate balance between those with and those without ICP monitoring through application of propensity matching weights. 29 Using matching weights leads to a weighted mean estimate that assigns more emphasis to individuals with propensity scores close to 0.50 than to those whose propensity scores close to 0 or 1. It represents an analog to 1-to-1 pair matching.
Secondary Outcome and Subgroup Analyses
Using identical methods, we also tested the association of ICP monitoring with mortality alone, with mortality or tracheos- tomy, and with mortality or GT placement. We assessed the association of our choice of matching weights by fitting outcome models using the 4 other most commonly used weighting estimates. As prespecified subgroup analyses, we fit separate propensity models for children with unintentional injuries, inflicted (intentional) injuries, age younger than 2 years, and age of 2 years or older. We then fit outcome models using the subgroup propensity scores as already described for the primary outcome. Post hoc, we performed subgroup analyses restricting the cohort to children with Abbreviated Injury Scale scores of 3 to 5 to compare our results with those of other observational studies, and we performed subgroup analyses using an exposure period of 48 hours instead of 24 hours.
Sensitivity Analyses
We measured the intensity of medical and surgical therapy typically directed at intracranial hypertension among children who did or did not undergo ICP monitoring. This measurement provides an indirect assessment of how clinicians responded to measured ICP and/or differences between groups that may have become apparent after the first day of admission and, therefore, would not have been included in the propensity model that balanced the groups. We also evaluated the properties that an unmeasured confounder would need to have to affect our results (eAppendix in the Supplement).
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Data analysis was conducted in R, version 3.4.0. 31 The code to generate the analysis was written using rmarkdown, 32 compiled using knitr, 33 and is entirely reproducible. The figures were generated using the ggplot2 34 package. P < .05 was considered statistically significant.
Results
Patient, Hospital, and Injury Characteristics
After exclusions, the study cohort included 3084 patients at 30 hospitals ( Figure 1 Figure 2 ).
Hospital Outcomes and Complications
Hospital mortality was 12.4% overall (n = 382) and 484 patients (15.7%) had the primary outcome of mortality, discharge to hospice, or poor functional survival ( 
Primary and Secondary Outcomes and Subgroup Analyses
Using propensity matching weights to adjust for patient-level differences and clustering by hospital, we found no statistically significant difference in functional survival between those who underwent ICP monitoring and those who did not (odds ratio [OR], 1.31; 95% CI, 0.99-1.74) ( Figure 3) . The point estimate was contrary to our hypothesis and reflected poorer outcomes among children who underwent ICP monitoring. In prespecified secondary analyses (also performed using matching weights), ICP monitoring was not significantly associated with hospital mortality (OR, 1.16; 95% CI, 0.89-1.50) but was associated with a higher likelihood of mortality, discharge to hospice, or either tracheostomy or GT placement. (Figure 3 ). Our choice of matching weights for propensity score weighting did not affect the results; otherwise, identical analyses using the 4 other most common propensity weighting strategies had similar overall results (eFigure 3 in the Supplement).
In prespecified subgroup analyses, we found no significant difference in functional survival between those who did and those who did not undergo ICP monitoring among children with unintentional injuries (OR, 1.35; 95% CI, 0.95-1.92), inflicted injuries (OR, 1.42; 95% CI, 0.91-2.22), and those 2 years of age or older (OR, 1.36; 95% CI, 0.96-1.91) or younger than 2 years of age (OR, 1.39; 95% CI, 0.90-2.13) (Figure 3) . Results of post hoc subgroup analyses are in the eAppendix in the Supplement. The following sensitivity analyses reflect, in general, the ways in which an unmeasured confounder could change the results of our study. With the current approach, a meaningful difference in the hypothesized direction is unlikely (eFigure 4 [upper panel] in the Supplement). Instead of no association, our study would show significant benefit from ICP monitoring only if both (1) the probability of having the confounder, given covariates, was at least 0.80 among those who underwent ICP monitoring and (2) the poor outcome, given ICP monitoring and covariates, was at least twice as likely among those with the confounder compared with those without the confounder. 30 Our study would instead show significant harm (eFigure 4 [lower panel] in the Supplement) from ICP monitoring if poor outcome, given ICP monitoring and covariates, was more likely among those without the confounder compared with those with the confounder.
Sensitivity Analyses
Discussion
In this large, multicenter, propensity-weighted analysis of children with severe TBI, we found no evidence of an association of ICP monitoring with functional survival. Mortality, a prespecified secondary outcome, also did not differ significantly between treatment groups. Children who underwent ICP monitoring had longer hospital stays and received more therapies directed at intracranial hypertension. This result is consistent with the results of a randomized trial of ICP monitoring of adults, 35 which found no difference in 6-month outcomes between care directed by ICP monitoring vs imaging and clinical examination. Although that trial has been criticized for its overall high mortality and the limited prehospital and postacute care available to the trial participants, it currently provides the best available evidence. 36 To our knowledge, no randomized trial of ICP monitoring has been conducted for children.
Strengths and Limitations
The present study has methodological advantages over several other observational studies of the outcome of ICP monitoring, including a robust sample size, validation of key database codes, appropriate confounder adjustment, consideration of clustering of patient outcomes by center, and a functional outcome measure more granular than mortality. In observational studies, selection bias in the distribution of ICP monitoring is highly likely unless propensity techniques are used to achieve covariate balance. To our knowledge, only one other observational study of ICP monitoring of children was both large and used propensity techniques. 8 That study showed ICP monitoring to be associated with improved survival but did not examine functional outcome.
One strength of the present study is the use of a primary outcome that captured not only hospital mortality but also survival with new and severe functional impairment requiring technological dependence at discharge. Although this outcome was not a nuanced functional or quality-of-life outcome assessment at 6 or 12 months after injury, it captures outcomes important to families and clinicians. One possible explanation for the lack of association is that some survivors received aggressive treatment, including ICP monitoring, but were ultimately left with severe impairment and new technological dependence. However, results of a secondary analysis with mortality as the outcome did not differ between the 2 groups. It is unlikely that our use of a broader outcome explains the difference between our study and that of Alali et al. 8 The present study was conducted using richer covariate data than previous observational studies of ICP monitoring. Because of the database linkage 14 and code validation 17 studies that we performed, the present study includes variables missing from some previous studies, such as injury mechanism, disposition in the ED, medications, and length of mechanical ventilation. All observational studies to date, including this one, have lacked information about computed tomography results and the progression of neurologic examination findings through the early hospital course. Those variables may be important to a decision about whether or not to place an ICP monitor and will be critical in any future prospective study of ICP monitoring. An additional limitation of the present study is that we used accurate phenotypes to identify clinical events, but the medical decision making that led to those events was not available in the databases we used.
In that light, our sensitivity analyses raise questions about between-group differences despite the seemingly excellent covariate balance we achieved. Children who underwent ICP monitoring had longer periods of mechanical ventilation and hospital stay and received more therapy directed at intracranial hypertension. It is possible that measured ICP led clinicians to make these choices, but it is a limitation that unmeasured differences (perhaps in computed tomography results or progression of GCS score) between those who received ICP monitors and those who did not may have contributed to subsequent treatment intensity. Given the possibility of unmeasured confounding, the data in this article should be interpreted as provocative, but we should not change the standard of care.
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One criticism of studies of ICP monitoring is that ICP monitoring is a diagnostic and surveillance technique and not a treatment per se. Because ICP monitoring is believed to be a lowrisk procedure, 37 it is unlikely to have a large direct benefit or cause harm. Any contributions to overall outcome are likely to operate through the benefits and risks of treatments ordered by clinicians because of the measured ICP. The present study does not allow for the separation of direct and indirect outcomes, but it can be viewed as estimating the overall association, incorporating both direct and indirect pathways.
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Conclusions
In this propensity-weighted analysis, we found no statistically significant association of ICP monitoring with functional survival of children with severe TBI. The 2 largest and most carefully analyzed retrospective studies of this important question have generated conflicting results. Because ICP monitoring is a widely but inconsistently used technology with incompletely demonstrated effectiveness, a large prospective cohort study or randomized trial is needed.
Statistical analysis: Bennett, DeWitt, Greene. 
eAppendix. Methods
Data Sources and Probabilistic Linkage PHIS
PHIS is a benchmarking and quality improvement database containing inpatient data from 44 U.S. children's hospitals with more than 500,000 discharges per year. 1 PHIS contains administrative data, diagnoses, and procedures as well as utilization information for pharmacy, imaging, laboratory, supply, nursing, and therapy services. These utilization data are coded using Clinical Transaction Classification (CTC) codes 2 and are grouped into 24-hour periods (days of service). PHIS data are only available to approved researchers at member hospitals. PHIS data are subjected to 175 reliability and validity checks and are accepted into the database when classified errors occur in <2% of a hospital's quarterly data.
3 Systematic data quality monitoring includes bimonthly coding consensus meetings, coding consistency reviews, and quarterly data quality reports. 4 
NTDB
The NTDB contains standardized trauma registry data from more than 3 million admissions at 900 trauma centers in the United States. 5 The NTDB contains no protected health information (PHI). The NTDB has a continuous data quality improvement process.
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Dataset Linkage
Briefly, we applied Markov chain Monte Carlo-augmented probabilistic linkage to records of injured children (< 18 years old at admission) in the NTDB and PHIS databases. We validated the accuracy of the linkage using identified data from a single center that submits to both databases. The linkage method is accurate for the patients in the current study: sensitivity 88%, positive predictive value (PPV) 98%, and specificity 99.99%. 6 In the context of the current dataset containing approximately 3,000 patients, a PPV of 98% suggests that as many as 60 patients might be false positive links. This is a limitation of the current dataset. False negatives in the validation linkage were found to be primarly patients who had short hospital stays (<72 hours) and were discharged home without new home care supports. 6 The original linkage was 2007-2010, and the same methods were applied to data from 2011-2012 to create the 2007-2012 cohort for this study.
Covariate Definitions
We coded the presence of "medical" complications such as cardiac arrest and seizures 7 using ICD-9-CM diagnosis codes from the PHIS file (eTable 1). For injury mechanism, injury type, and specific injury diagnoses including abuse/assault 9, 10 , we used ICD-9-CM diagnosis codes from the NTDB file. We categorized injury mechanism using the external cause-of-injury matrix created by the CDC (with ICD-9-CM diagnosis code 995.5 added to the child abuse/assault category) and injury type using the Barell matrix. 11, 12 Injury severity score (ISS) and abbreviated injury scale (AIS) scores were generated by trauma registrars at each site (these are available in the NTDB). We defined specific intracranial hemorrhage types using the "predot" AIS codes. 13 We defined hypotension using standard Pediatric Advanced Life Support criteria based on the pre-hospital and ED vital signs present in the NTDB.
14 Drugs were identified using Clinical Transaction Classification (CTC) codes from the PHIS database.
Post hoc Subgroup Analyses
When we restricted the cohort to subjects with head AIS scores 3-5, we found that ICP monitoring was associated with worse functional survival: odds ratio 1.36 (95% CI 1.01-1.85). When we used an exposure period of 48 instead of 24 hours and restricted the cohort to those with a length of stay of at least 48 days, we also found ICP monitoring was associated with worse functional survival: OR 1.46 (95% CI 1.04-2.06). These analyses were otherwise identical to the primary analysis.
Sensitivity Analyses
We evaluated the likelihood of unmeasured confounding using the approach established by VanderWeele. 15 To do so, we considered an unmeasured confounder such as a binary variable where U = 1 represented that a patient's GCS score did not improve to a certain level after all sedatives were metabolized. U = 0 would represent that a patient's GCS did improve to that level when off of sedation. The unmeasured confounder could also be a composite of neurologic exam findings. We then estimated the effect of such an unmeasured confounder across ranges of probabilities of a) bad outcome given ICP monitor placement with U = 1, b) bad outcome given ICP monitor placement with U = 0, c) U = 1 given ICP monitor placement and a matrix of covariates, and d) U = 1 given no ICP monitor placement and a matrix of covariates. See eFigure 4.
